Marie Louise Roed Rasmussen, YO Chair, invites you to the next YO meeting in Brussels in July 2020

The Boston Keratoprosthesis type II (BK2) device may be the only viable option to salvage vision in patients with severe cicatrizing ocular surface disease. The prior BK2 model was modified to the present day (click-on) model in 2009. The clinical outcomes of the current click-on BK2 model is discussed in this touchOPHTHALMOLOGY interview with Dr […]

When capturing a scleral image in the biometry occasionally an error message can appear as “not enough vessels near the limbus have been found”, in consequence, using the intraoperative toric axis assistant is not possible. Timolol 0.25% is a common and available non-selective beta-adrenergic blocker. The use of topical timolol 0.25% drops as an effective […]

The clinical outcomes of the GEMINI 1 and GEMINI 2 studies are discussed in this touchOPHTHALMOLOGY interview with Prof. Christopher Lievens (Southern College of Optometry, Memphis, Tennessee, USA). If approved, AGN-190584 is expected to be the first eye drop for the treatment of presbyopia, the eye’s reduced ability to focus on near objects. The presentation […]